|
|
|
|
||
Re: ASH Late Breaking Abstracts: Prediction: Sangamo will not file one for Hemo A because Pfizer is running the show...an international meeting like this would allow sgmo/pfe to announce interim data specific to the sb-525 trial and not violate the prepublication restrictions that ASH requires. |
return to message board, top of board |